| 000 | 01809 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516172013.0 | ||
| 264 | 0 | _c20140210 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1096-0333 | ||
| 024 | 7 |
_a10.1016/j.taap.2013.09.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHan, Jinbin | |
| 245 | 0 | 0 |
_aA binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cDec 2013 |
||
| 300 |
_a477-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinogenesis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCopper _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDisulfiram _xpharmacology |
| 650 | 0 | 4 |
_aDitiocarb _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProteasome Endopeptidase Complex _xmetabolism |
| 650 | 0 | 4 |
_aProteasome Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aLiu, Luming | |
| 700 | 1 | _aYue, Xiaoqiang | |
| 700 | 1 | _aChang, Jinjia | |
| 700 | 1 | _aShi, Weidong | |
| 700 | 1 | _aHua, Yongqiang | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 273 _gno. 3 _gp. 477-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2013.09.009 _zAvailable from publisher's website |
| 999 |
_c23111607 _d23111607 |
||